These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 8272230)

  • 1. Prevention of blood loss in dialysers with DEAE-cellulose membranes does not require increased doses of heparin.
    Ward RA; Schmidt B; Gurland HJ
    Nephrol Dial Transplant; 1993; 8(10):1140-5. PubMed ID: 8272230
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Low-dose heparinization can be used with DEAE-cellulose hemodialysis membranes.
    Ward RA; Schmidt B; Gurland HJ
    ASAIO Trans; 1990; 36(3):M321-4. PubMed ID: 2252689
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical comparison of high-flux cellulose acetate and synthetic membranes.
    Hoenich NA; Woffindin C; Matthews JN; Goldfinch ME; Turnbull J
    Nephrol Dial Transplant; 1994; 9(1):60-6. PubMed ID: 8177478
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of vitamin-E-modified dialysers on dialyser clotting, erythropoietin and heparin dosage: a comparative crossover study.
    Huraib S; Tanimu D; Shaheen F; Hejaili F; Giles C; Pagayon V
    Am J Nephrol; 2000; 20(5):364-8. PubMed ID: 11092992
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Binding and desorption of heparin to DEAE-cellulose dialysis membranes].
    Schmitt E; Holtz M; Esther G; Courtney JM; Klinkmann H
    Z Urol Nephrol; 1983; 76(2):99-108. PubMed ID: 6858414
    [No Abstract]   [Full Text] [Related]  

  • 6. [Clinical study of biocompatibility of dialysis membranes made from non-modified and modified cellulose].
    Opatrný K; Sulková S; Vít L; Vienken J; Körwer-Uhlenbusch I; Sefrna F; Válek A; Bláha J
    Cas Lek Cesk; 1992 Aug; 131(15):457-61. PubMed ID: 1423453
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of two dialysers (AN69ST vs. FX100) for heparin-free dialysis in patients with oral anticoagulation.
    Kodras K; Benesch T; Neumann I; Haas M
    Blood Purif; 2008; 26(3):226-30. PubMed ID: 18305385
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Optimal anticoagulation strategy in haemodialysis with heparin-coated polyacrylonitrile membrane.
    Lavaud S; Canivet E; Wuillai A; Maheut H; Randoux C; Bonnet JM; Renaux JL; Chanard J
    Nephrol Dial Transplant; 2003 Oct; 18(10):2097-104. PubMed ID: 13679486
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The influence of dialyzer geometry on blood coagulation and biocompatibility.
    Lins LE; Boberg U; Jacobson SH; Kjellstrand C; Ljungberg B; Skröder R
    Clin Nephrol; 1993 Nov; 40(5):281-5. PubMed ID: 8281717
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recombinant human antithrombin III restores heparin responsiveness and decreases activation of coagulation in heparin-resistant patients during cardiopulmonary bypass.
    Avidan MS; Levy JH; van Aken H; Feneck RO; Latimer RD; Ott E; Martin E; Birnbaum DE; Bonfiglio LJ; Kajdasz DK; Despotis GJ
    J Thorac Cardiovasc Surg; 2005 Jul; 130(1):107-13. PubMed ID: 15999048
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Coagulation and fibrinolytic profiles and appropriate use of heparin after living-donor liver transplantation.
    Kaneko J; Sugawara Y; Tamura S; Togashi J; Matsui Y; Akamatsu N; Kishi Y; Makuuchi M
    Clin Transplant; 2005 Dec; 19(6):804-9. PubMed ID: 16313329
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of membrane choice and blood flow pattern on coagulation and heparin requirement--potential consequences on lipid concentrations.
    Sperschneider H; Deppisch R; Beck W; Wolf H; Stein G
    Nephrol Dial Transplant; 1997 Dec; 12(12):2638-46. PubMed ID: 9430865
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antithrombotic properties of dermatan sulphate (MF 701) in haemodialysis for chronic renal failure.
    Ryan KE; Lane DA; Flynn A; Ireland H; Boisclair M; Shepperd J; Curtis JR
    Thromb Haemost; 1992 Nov; 68(5):563-9. PubMed ID: 1455403
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increased binding of beta-2-microglobulin to blood cells in dialysis patients treated with high-flux dialyzers compared with low-flux membranes contributed to reduced beta-2-microglobulin concentrations. Results of a cross-over study.
    Traut M; Haufe CC; Eismann U; Deppisch RM; Stein G; Wolf G
    Blood Purif; 2007; 25(5-6):432-40. PubMed ID: 17957097
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Acute effect of haemodialysis on arterial stiffness: membrane bioincompatibility?
    Mourad A; Carney S; Gillies A; Jones B; Nanra R; Trevillian P
    Nephrol Dial Transplant; 2004 Nov; 19(11):2797-802. PubMed ID: 15340092
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Clinical usefulness of Nephral ST dialyzers in hemodialyzed patients with increased risk of bleeding].
    Kopeć J; Sułowicz W
    Przegl Lek; 2010; 67(2):91-4. PubMed ID: 20557006
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Heparin is unable to prevent contact activation by three different membranes.
    Stratta P; Canavese C; Mangiarotti G; Pacitti A; Tetta C; Coppo R; Ragni R; Vercellone A
    Proc Eur Dial Transplant Assoc; 1981; 18():269-74. PubMed ID: 6460241
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of haemodialysis membrane biocompatibility by parallel assessment in an ex vivo model in healthy volunteers.
    Mulvihill J; Crost T; Renaux JL; Cazenave JP
    Nephrol Dial Transplant; 1997 Sep; 12(9):1968-73. PubMed ID: 9306352
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Different effects of enoxaparin and unfractionated heparin on some thrombogenesis markers during hemodialysis: a cross-over study.
    Naumnik B; Pawlak K; Myśliwiec M
    Thromb Res; 2009 Feb; 123(4):631-6. PubMed ID: 18234290
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Heparin-coated polyacrylonitrile membrane versus regional citrate anticoagulation: a prospective randomized study of 2 anticoagulation strategies in patients at risk of bleeding.
    Evenepoel P; Dejagere T; Verhamme P; Claes K; Kuypers D; Bammens B; Vanrenterghem Y
    Am J Kidney Dis; 2007 May; 49(5):642-9. PubMed ID: 17472846
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.